HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha.

Abstract
We have reported previously that PX-478 (S-2-amino-3-[4'-N,N,-bis(chloroethyl)amino]phenyl propionic acid N-oxide dihydrochloride) has potent antitumor activity against a variety of human tumor xenografts associated with the levels of the hypoxia-inducible factor-1alpha (HIF-1alpha) within the tumor. We now report that PX-478 inhibits HIF-1alpha protein levels and transactivation in a variety of cancer cell lines. Hypoxia-induced vascular endothelial growth factor formation was inhibited by PX-478, whereas baseline levels of vascular endothelial growth factor in normoxia were unaffected. Studies of the mechanism of PX-478 action showed that HIF-1alpha inhibition occurs in both normoxia and hypoxia and does not require pVHL or p53. In addition, PX-478 decreases levels of HIF-1alpha mRNA and inhibits translation as determined by 35S labeling experiments and reporter assays using the 5' untranslated region of HIF-1alpha. Moreover, to a lesser extent, PX-478 also inhibits HIF-1alpha deubiquitination resulting in increased levels of polyubiquitinated HIF-1alpha. The inhibitory effect of PX-478 on HIF-1alpha levels is primarily due to its inhibition of translation because HIF-1alpha translation continues in hypoxia when translation of most proteins is decreased. We conclude that PX-478 inhibits HIF-1alpha at multiple levels that together or individually may contribute to its antitumor activity against HIF-1alpha-expressing tumors.
AuthorsMei Y Koh, Taly Spivak-Kroizman, Sara Venturini, Sarah Welsh, Ryan R Williams, D Lynn Kirkpatrick, Garth Powis
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 7 Issue 1 Pg. 90-100 (Jan 2008) ISSN: 1535-7163 [Print] United States
PMID18202012 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • 2-amino-3-(4'-N,N-bis(2-chloroethyl)amino)phenylpropionic acid N-oxide
  • Antineoplastic Agents
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Mustard Compounds
  • Phenylpropionates
  • Tumor Suppressor Protein p53
Topics
  • Antineoplastic Agents (chemistry, pharmacology)
  • Cell Line, Tumor
  • Cell Nucleus (drug effects, metabolism)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (genetics, metabolism)
  • Molecular Structure
  • Mustard Compounds (chemistry, pharmacology)
  • Phenylpropionates (chemistry, pharmacology)
  • Protein Biosynthesis (drug effects, genetics)
  • Sensitivity and Specificity
  • Time Factors
  • Transcription, Genetic (drug effects, genetics)
  • Transcriptional Activation (drug effects)
  • Tumor Suppressor Protein p53 (genetics, metabolism)
  • Ubiquitination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: